Tag: nonvalvular atrial fibrillation

Boston Scientific Corporation WATCHMAN FLX Device
March 15, 2023/Electrophysiology

Watchman FLX at 1 Year: Real-World Performance Consistent With Trial Results

Large SURPASS registry study confirms high seal rates, acceptable safety

The Featured Image for the post
March 16, 2022/Electrophysiology

SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days

Interim report from large registry analysis compares favorably with pivotal trial

21-HVI-2489560-Watchman 1000+_650x450
November 9, 2021/Electrophysiology

Insights From 1,000+ Left Atrial Appendage Closure Procedures With Watchman

Even very high-risk patients benefit, and implantation can safely be combined with ablation or TAVR

19-HRT-036-WatchmanInICH-650×450
February 6, 2019/Advancing Patient Care

Left Atrial Appendage Closure Device Found Safe and Effective for AF Despite Prior ICH

Study supports new stroke prevention option for high-risk group

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-HRT-154-Watchman-CQD-1
May 11, 2018/Research

Watchman in the Real World: Reports on Use in High-Risk Patients and Overall Safety

Recaps of three studies from Cleveland Clinic’s experience to date

Oussama Wazni, MD
June 18, 2015/News & Insights

LAA Closure Device a Reality: Now What? (Video)

An expert’s take on FDA’s ‘appropriate rationale’ caveat

BackPage 1 of 1Next
Advertisement
Ad